This bill would prohibit an occupational licensing board from taking adverse action against a physician who recommends a COVID-19 treatment that is not FDA-approved
This bill would require a patient's written, informed consent to receive a physician's recommended COVID-19 treatment if the treatment is not FDA-approved
This bill would require pharmacies to fulfill prescriptions that are not FDA-approved to treat COVID-19
This bill would require health care facilities to provide a patient's requested off-label use COVID-19 treatment
This bill would provide a cause of action against an occupational licensing board, pharmacy, or health care facility that violates the provisions of this bill
Relating to COVID-19; to prohibit an occupational licensing board from taking adverse action against a physician who recommends certain COVID-19 treatments; to require a patient's written, informed consent to certain COVID-19 treatments; to require health care facilities and pharmacies to provide certain COVID-19 treatments that are not approved by the FDA; and to create a cause of action.
|March 8, 2022||H||Read for the first time and referred to the House of Representatives committee on Judiciary|
|Bill Text||HB470 Alabama 2022 Session - Introduced|